| 1.16 Data as of May 20 |  -0.04 / -3.33%Today’s Change | 0.57 Today|||52-Week Range 1.46 | +75.76% Year-to-Date |
| Previous close | 1.20 |
| Today’s open | 1.19 |
| Day’s range | -- - -- |
| Volume | 690,269 |
| Average volume (3 months) | 1,206,808 |
| Market cap | $178.3M |
| Dividend yield | -- |
| Earnings growth (last year) | +47.22% |
| Earnings growth (this year) | -4.86% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +88.98% |
| P/E ratio | NM |
| Price/Sales | 9.49 |
| Price/Book | 2.44 |
| Today’s change | Today’s % change | |
|---|---|---|
| TRGTTargacept Inc | +0.06 | +1.09% |
| NUTRNutraceutical Intern... | +0.08 | +0.41% |
| BLGXBiologix Hair Inc | 0.00 | 0.00% |
| NATRNature's Sunshine Pr... | +0.68 | +4.44% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $7.6M |
| Annual profit (last year) | -$40.4M |
| Net profit margin | -534.07% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Robert I. Blum, MBA |
Chief Financial Officer, Secretary & Executive VP Sharon A. Barbari |
Corporate headquarters South San Francisco, California |
.
